SILIQ
SILIQ
Approved
DIN Number
02473623
Drug Class
Human
Market Date
Jul 5, 2018
Company
HC
bausch health, canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02473623
AIG Number0160070001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AC12 BRODALUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification84:06.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
BRODALUMABActive
Strength: 210 MG / 1.5 ML
Monograph: BRODALUMAB